December 19, 2014 9:30 AM ET

Healthcare Equipment and Supplies

Company Overview of IMCOR Pharmaceutical Co.

Company Overview

IMCOR Pharmaceutical Co. does not have significant operations. It owns Imagent, an ultrasound imaging contrast agent for use in patients with suboptimal echocardiograms. Prior to April 2005, the company engaged in the development and marketing of medical imaging pharmaceutical products. IMCOR was founded in 1994 as MT Financial Group, Inc. and changed its name to Photogen Technologies, Inc. in 1997. Later, it changed its name to IMCOR Pharmaceutical Co. in 2004. The company is headquartered in San Diego, California.

4660 La Jolla Drive

Suite 500

San Diego, CA 92122

United States

Founded in 1994

Phone:

858-546-2955

Fax:

858-410-5602

Key Executives for IMCOR Pharmaceutical Co.

Chairman
Age: 65
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Doctors Research Group, Inc. United States
Fast Medical, Inc. United States
Dispense Labs, LLC United States
Atlanta-International Prosthetic & Orthotic Marketing Inc. United States
Johnson's Orthopedic Designs, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMCOR Pharmaceutical Co., please visit www.imcorpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.